Form 4: Surgery Partners Executive Sells Shares to Cover Tax Obligations

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 5,681 shares of common stock on February 7, 2025, to cover tax obligations related to vesting restricted stock.

Summary

• On February 7, 2025, Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 5,681 shares of the company's common stock.
• The sale was executed at a weighted average price of $25.83 per share.
• This transaction was done to satisfy tax withholding obligations related to the vesting of restricted stock on January 31, 2025.
• Following the transaction, Baldock directly owns 200,172 shares of Surgery Partners' common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an insider stock sale for tax purposes. It doesn't convey strong positive or negative sentiment.

Industry Context

Insider sales are a common occurrence, especially to cover tax obligations related to stock vesting. The sale itself doesn't necessarily indicate a negative outlook on the company, but it's something investors often monitor.

Stakeholder Impact

• The sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the volume is relatively small compared to the total outstanding shares.

Key Dates